Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies

被引：0

作者：

Jing-dong Zhou

Yu-xin Wang

Ting-juan Zhang

Xi-xi Li

Yu Gu

Wei Zhang

Ji-chun Ma

Jiang Lin

Jun Qian

机构：

[1] Affiliated People’s Hospital of Jiangsu University,Department of Hematology

[2] The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City,Department of Nephrology and Endocrinology

[3] Traditional Chinese Medicine Hospital of Kunshan City,Laboratory Center

[4] Affiliated People’s Hospital of Jiangsu University,undefined

来源：

Clinical Epigenetics | 2018年 / 10卷

关键词：

Methylation; Biomarker; MDS; AML;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 394 条

[1]

Estey E(2006)Acute myeloid leukaemia Lancet 368 1894-1907

[2]

Döhner H(2014)Myelodysplastic syndromes Lancet 383 2239-2252

[3]

Adès L(2008)Chromosomal translocations: revisited yet again Blood 112 2183-2189

[4]

Itzykson R(2011)Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications J Clin Oncol 29 475-486

[5]

Fenaux P(2010)Leukaemogenesis: more than mutant genes Nat Rev Cancer 10 23-36

[6]

Rowley JD(2010)Active DNA demethylation: many roads lead to Rome Nat Rev Mol Cell Biol 11 607-620

[7]

Marcucci G(2010)Cancer epigenetics CA Cancer J Clin 60 376-392

[8]

Haferlach T(2009)Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Blood 113 1315-1325

[9]

Döhner H(2017)Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies J Cell Mol Med 21 1468-1481

[10]

Chen J(2000)Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators Dev Biol 227 239-255